Allogene Therapeutics, Inc. (ALLO)

CIK 1737287 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Allogene Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 2, 20268-K0001193125-26-379423
Aug 25, 202640001628280-26-058920
Aug 21, 20261440001737287-26-000023
Aug 20, 2026EFFECT9999999995-26-002725
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000912
Aug 12, 20268-K0001628280-26-056198
Aug 12, 2026S-30001628280-26-056232
Aug 12, 202610-Q0001628280-26-056213
Aug 7, 2026SCHEDULE 13G/A0001296549-26-000008
Aug 7, 2026SCHEDULE 13G0000093751-26-000405
Jul 6, 202640001851044-26-000005
Jun 23, 202640001197020-26-000002
Jun 23, 202640001221355-26-000002
Jun 23, 202640001548072-26-000002
Jun 23, 202640001737287-26-000021
Jun 23, 202640001737287-26-000019
Jun 23, 202640001700969-26-000002
Jun 23, 202640001764157-26-000004
Jun 22, 20268-K0001628280-26-044618
Jun 22, 2026424B50001628280-26-044616
May 28, 2026DEFA14A0001193125-26-245501
May 28, 20268-K0001193125-26-245484
May 21, 2026DEFA14A0001628280-26-036992
May 15, 2026SCHEDULE 13G/A0001104659-26-062730
May 15, 2026SCHEDULE 13G/A0000902664-26-002534